By converging ultrasound energy at precise focal points, FUS can destroy tissue or open the blood-brain barrier without a ...

Presented initial data from Phase 1b study suggesting GT-02287 has a disease-slowing effect consistent with the preclinical ...

As of November 12, 2025, ProMIS has fully enrolled Cohorts 1 and 2 and is well into Cohort 3, with complete enrollment ...

The longstanding partnership between The Michael J. Fox Foundation for Parkinson's Research (MJFF) and the Edmond J. Safra Foundation continues to open the door toward scientific advances and ...

Parkinson’s disease steals ease and movement by striking a narrow band of midbrain neurons. If you study or cover neuroscience, you have seen the promise and frustration in efforts to grow these ...

In a promising medical discovery that could transform early detection of 'Parkinson's disease' (Parkinsonism), a team of ...

Researchers have uncovered a shared brain cell breakdown mechanism behind Alzheimer’s and Parkinson’s diseases, revealing how ...

A man who was diagnosed with Parkinson's five years ago days he has "got his life back" thanks to a prescription for medical ...

GOTHENBURG, SE / ACCESS Newswire / November 7, 2025 / IRLAB Therapeutics AB (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, today announced that ...

NeuroDiscovery AI offers a specialised AI platform for neurology that helps doctors diagnose brain diseases and ...

Symptoms of Parkinson’s disease, which afflicts around 1 million Americans, usually begin gradually and worsen over time.

Parkinsons’s disease, a progressive neurological movement disorder, impacts the lives of those affected by the condition.